Yao Xie Selected Research

tryptophyltryptophan

1/2012	Polymorphisms of XRCC1 and ADPRT genes and risk of noncardia gastric cancer in a Chinese population: a case-control study.
1/2012	ADPRT Val762Ala and XRCC1 Arg194Trp polymorphisms and risk of gastric cancer in Sichuan of China.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yao Xie Research Topics

Disease

54	Chronic Hepatitis B 03/2024 - 08/2003
31	Infections 12/2023 - 02/2004
25	Hepatitis B 12/2023 - 06/2004
24	Neoplasms (Cancer) 01/2023 - 07/2008
17	Chronic Hepatitis C 09/2019 - 02/2004
9	Inflammation (Inflammations) 12/2023 - 11/2017
7	Fibrosis (Cirrhosis) 01/2022 - 08/2003
6	Hepatitis 02/2023 - 06/2007
6	Liver Cirrhosis (Hepatic Cirrhosis) 06/2022 - 08/2003
6	Body Weight (Weight, Body) 01/2020 - 08/2004
5	Stomach Neoplasms (Stomach Cancer) 01/2023 - 01/2012
4	Ischemia 01/2023 - 03/2019
4	Hepatocellular Carcinoma (Hepatoma) 09/2022 - 09/2017
4	Cardiovascular Diseases (Cardiovascular Disease) 05/2022 - 01/2019
3	Wounds and Injuries (Trauma) 10/2023 - 01/2022
3	Alzheimer Disease (Alzheimer's Disease) 02/2023 - 04/2005
3	Heart Failure 01/2023 - 09/2017
3	Liver Diseases (Liver Disease) 06/2022 - 08/2004
3	Ischemic Stroke 01/2022 - 01/2021
3	Carcinoma (Carcinomatosis) 11/2021 - 10/2013
3	Vascular Remodeling 01/2021 - 01/2018
3	Cardiomegaly (Heart Hypertrophy) 01/2021 - 09/2017
3	Viremia 01/2021 - 01/2021
2	Mitochondrial Diseases (Mitochondrial Disease) 02/2024 - 11/2021
2	Hemorrhage 01/2024 - 10/2013
2	Breast Neoplasms (Breast Cancer) 10/2023 - 09/2020
2	COVID-19 07/2023 - 01/2023
2	Hypoxia (Hypoxemia) 01/2023 - 01/2018
2	Myocardial Infarction 01/2022 - 09/2017
2	Melanoma (Melanoma, Malignant) 01/2022 - 01/2021
2	Hyperplasia 01/2022 - 01/2021
2	Disease Progression 01/2022 - 09/2017
2	Nasopharyngeal Carcinoma 01/2022 - 01/2012
2	Chronic Hepatitis (Chronic Active Hepatitis) 01/2022 - 08/2003
2	Neuroblastoma 07/2021 - 07/2014
2	Ovarian Neoplasms (Ovarian Cancer) 01/2021 - 01/2013
2	Neoplasm Metastasis (Metastasis) 01/2021 - 06/2019
2	Uterine Cervical Neoplasms (Cancer of the Cervix) 12/2020 - 05/2013
2	Substance-Related Disorders (Drug Abuse) 01/2020 - 01/2019
2	Dermatomyositis (Dermatopolymyositis) 08/2012 - 03/2012
2	Polymyositis 08/2012 - 03/2012
2	Prostatic Neoplasms (Prostate Cancer) 07/2008 - 03/2008

Drug/Important Bio-Agent (IBA)

38	Hepatitis B e AntigensIBA 12/2023 - 08/2003
28	Hepatitis B Surface Antigens (HBsAg)FDA Link 03/2024 - 08/2008
28	Antiviral Agents (Antivirals)IBA 12/2023 - 08/2003
27	InterferonsIBA 03/2024 - 08/2004
18	AntigensIBA 12/2023 - 08/2003
16	DNA (Deoxyribonucleic Acid)IBA 01/2023 - 08/2003
12	CytokinesIBA 06/2022 - 08/2017
11	peginterferon alfa-2a (Pegasys)FDA Link 01/2022 - 02/2004
10	Alanine Transaminase (SGPT)IBA 03/2023 - 07/2017
9	RNA (Ribonucleic Acid)IBA 06/2023 - 02/2004
9	Proteins (Proteins, Gene)FDA Link 01/2023 - 10/2007
7	Interferon alpha-2 (Roferon-A)FDA Link 03/2023 - 02/2004
7	Biomarkers (Surrogate Marker)IBA 12/2022 - 08/2012
5	Interferon-alpha (Interferon Alfa)IBA 01/2023 - 02/2011
5	NucleotidesIBA 01/2022 - 01/2013
5	entecavir FDA Link 01/2022 - 12/2014
5	Ribavirin (Virazole)FDA LinkGeneric 09/2019 - 12/2006
4	AntibodiesIBA 12/2022 - 10/2007
4	Immune Checkpoint InhibitorsIBA 12/2022 - 01/2019
4	Messenger RNA (mRNA)IBA 01/2021 - 07/2008
3	Immunoglobulins (Immunoglobulin)IBA 01/2023 - 12/2021
3	Therapeutic UsesIBA 05/2022 - 05/2005
3	NucleosidesIBA 01/2022 - 11/2015
3	Lamivudine (Epivir)FDA Link 12/2021 - 01/2017
3	Transforming Growth Factors (Transforming Growth Factor)IBA 10/2021 - 08/2017
3	EnzymesIBA 12/2015 - 03/2008
3	ImmunosorbentsIBA 12/2015 - 03/2008
2	CholesterolIBA 06/2023 - 01/2017
2	Tenofovir (Viread)FDA Link 02/2023 - 01/2021
2	Hepatitis B Vaccines (Hepatitis B Vaccine)IBA 01/2023 - 10/2022
2	Calcium-Calmodulin-Dependent Protein Kinase Type 2IBA 01/2023 - 01/2023
2	CalpainIBA 01/2023 - 01/2021
2	CalciumIBA 01/2023 - 01/2021
2	Prothrombin (Factor II)IBA 01/2022 - 06/2007
2	AlbuminsIBA 01/2022 - 10/2013
2	Proteoglycans (Proteoglycan)IBA 01/2022 - 03/2019
2	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2022 - 08/2019
2	lipoarabinomannan (LAM)IBA 12/2021 - 01/2017
2	Telbivudine FDA Link 12/2021 - 01/2021
2	CarbohydratesIBA 01/2021 - 12/2015
2	Trifluoperazine (Stelazine)FDA LinkGeneric 01/2021 - 01/2019
2	Antipsychotic Agents (Antipsychotics)IBA 01/2021 - 01/2019
2	LigandsIBA 01/2019 - 01/2019
2	Interleukin-10 (Interleukin 10)IBA 08/2017 - 01/2013
2	ADP Ribose Transferases (ADP Ribosyltransferase)IBA 01/2012 - 01/2012
2	tryptophyltryptophanIBA 01/2012 - 01/2012
2	Amyloid beta-PeptidesIBA 10/2007 - 04/2005
1	Mitochondrial DNA (mtDNA)IBA 02/2024
1	Electron Transport Complex III (Coenzyme Q-Cytochrome-c Reductase)IBA 02/2024

Therapy/Procedure

49	Therapeutics 03/2024 - 02/2004
8	Drug Therapy (Chemotherapy) 10/2023 - 03/2008
6	Aftercare (After-Treatment) 01/2022 - 05/2005
4	Transplantation 05/2022 - 10/2019
3	Radiotherapy 10/2023 - 01/2019
3	Chinese Traditional Medicine (Traditional Chinese Medicine) 01/2023 - 01/2022
3	Immunotherapy 06/2022 - 01/2019
2	Microspheres (Microsphere) 01/2023 - 07/2020
2	Subcutaneous Injections 09/2019 - 03/2011